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Reclaiming the Human Genome: 
A Philosophical Perspective
The human genome sequence has become central to ethical and policy debates on the application of genetic research to biomedicine and biotechnology. 
It is also shaping contemporary ideas about our humanness with scholars using 
the powerful scriptural metaphor of the “Book of Man” to refer to the human 
genome and likening its decoding to the search for the “Holy Grail.”
Considering the benefits to mankind that the Human Genome Project 
promised to all those who could exploit it, the race to grab our DNA through 
the patenting system was inevitable. But when the first patent was issued way 
back in 1449 by King Henry VI to John of Utynam for a method of making 
stained glass, with the proviso that the inventor must teach his art to others, 
the situation was very different from what it is today, where patents are being 
sought for human genes and academic research can be commercialized as a result 
of the Bayh-Dole Act of 1980.1 Preoccupied that the patenting of human genes 
may lead to illegal profiteering from the human genome, several international 
bodies such as the United Nations Educational, Scientific, and Cultural 
Organization (UNESCO), the World Medical Association and the Human 
Genome Organization (HUGO) have all adopted specific statements about 
DNA patenting. While HUGO2 declared that those who participate in genetic 
studies should receive some benefits from participation, both UNESCO and 
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the World Medical Association3 have declared the human genome as common 
heritage of mankind, and condemned any commercial benefit from the human 
genome in its natural state.4 The World Medical Association has even urged 
medical organizations around the world to lobby against gene patenting.5
Modern Science and the Human Genome
The problem is that today the patenting system which sees the human genome 
as public property rather than common resource is supported by several scientists 
who choose to look upon the individual human being as nothing more than a 
“combinatorial unit of reassorted molecules.” Metaphysically this is analogous to 
saying we are only DNA making more DNA. And when you reduce the individual 
to a “combinatorial unit of reassorted molecules,” you are in effect doing two 
things: on the one hand, reducing the individual to a complex entity made up 
of essentially non-living entities that have no moral value, and on the other 
hand, denying that the individual human being can be the subject of morality. 
The individual is divested of all moral value because morality only belongs to 
the living and when you consider the individual as a combination of non-living 
entities, there is no longer any place for moral conclusions. The problem with 
this position is that it tends to deny the need to adopt a metaphysical account 
of human nature which is essential for addressing fundamental bioethical issues. 
Some bioethicists, in the empiricist tradition of David Hume, go so far as to 
deny that metaphysics can have any relevance to biomedical issues. This position 
is strongly contested by other authors who believe that a metaphysical account 
of human nature is necessary to discuss ethical issues and therefore reject any 
form of reductionist thinking. It is unfortunate that there has not been a serious 
moral discussion between biologists, who deny the relevance of metaphysics to 
biomedical issues, and philosophers, who hold that it is impossible to discuss 
these issues without metaphysical considerations.
Unfortunately, modern scientific thought has been taken over by a 
predominantly mechanistic understanding of Darwinism which rejects any 
form of teleological theory about the moral significance of the individual 
human being. It is an established fact, that for many biologists today, the 
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chemical explanation of life and evolution has no need of resorting to the idea 
of purpose or to what Aristotle termed “final cause.” Modern biology has no 
use for “teleological” explanations; physico-chemical explanations are sufficient! 
According to Daniel C. Dennett, Darwin effectively put an end to any form of 
teleological thinking about the purpose and meaning of human life, when he 
showed that the evolutionary process was the result of a mindless, algorithmic 
process, which he termed “natural selection.”6
This position is very contrary to that of several contemporary philosophers 
who are beginning to think of the human genome as embodying our humanness, 
determining both our individuality and our species-identity. This genomic 
metaphysics sees the genome as being the true essence of human nature, with 
external influences considered as accidental events. This notion of the human 
genome is very similar to the Aristotelian notion of eidos which is the organizing 
principle inherent in every living thing. Aristotle and Aquinas saw eidos as closely 
connected to the notion of soul, which gave a living organism its distinguishing 
characteristics as well as the essence of the organism’s species. For Aristotle, it 
was not only human beings who had a soul but so did plants and animals with a 
vegetative and sensitive soul respectively.
With the human embryo denied its moral status or forma as the embodiment 
of our species-identity and personal identity, and reduced to a “blob of cells” 
or a “conglomeration of re-assorted molecules,” the slippery slope to the 
patenting and commercialization of the human genome was inevitable. Modern 
scientific thought believes that Darwin provides the only feasible solution to 
the deep problem of man’s existence. It stands to reason that this position not 
only undermines the consideration that the human genome constitutes the 
distinctive element that is specific to each individual as a component of his or 
her uniqueness, but also undermines the consideration that the human genome 
should not be made the object of appropriation as it is a “common resource.”
But the crux of the matter is that Darwin’s theory of natural selection, and 
Aristotle’s teleological approach to human nature, are not mutually exclusive. 
Darwin never meant to reject all teleological ideas about life and nature. Leon 
Kass has argued that Darwinism cannot be correctly understood without the 
notion of teleology.7 The root of the problem lies with the tendency of the 
modern mind to appropriate science and the scientific method for its own anti-
metaphysical ends, thus reducing rational analysis to reductionism with its 
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inherent scepticism. When one is able to go beyond the reductionist approach 
to natural science, it becomes evident, from an accurate reading of Darwin’s The 
Origin of the Species, that in explaining natural selection, Darwin was in fact 
mainly concerned with explaining the teleological character of living organisms. 
In his introduction to The Origin of the Species, Darwin wrote:
In considering the Origin of Species, it is quite conceivable that a naturalist, 
reflecting on the mutual affinities of organic beings, on their embryological 
relations, their geographical distribution, geological succession, and other such 
facts, might come to the conclusion that species had not been independently 
created, but had descended, like varieties, from other species. Nevertheless, such a 
conclusion, even if well founded, would be unsatisfactory, until it could be shown 
how the innumerable species inhabiting this world have been modified, so as to 
acquire that perfection of structure and coadaptation which justly excites our 
admiration.8
Darwin was therefore interested in explaining not only the internal 
purposiveness which was to be found in plants and animals, but also the 
underlying reason for the perfection which he could observe, not only in their 
structure but also in the ordered set of relations which governed their activity as 
members of the same kind. In fact, Darwin succeeds in giving a non-teleological 
account of the origin and basis for the teleological character of organisms by 
demonstrating that his non-teleological explanation of natural selection depends 
upon the immanent teleological character of organisms.
With his theory of natural selection Darwin explained the essential connection 
that exists between the desire to be found in living organisms to survive and 
propagate, and the teleological nature of these organisms. In other words, it is 
the teleological nature of life that provides the nexus between natural selection 
and the miracle of the continuity of life. At the heart of natural selection is the 
teleological nature of these organisms. These organisms survive because they are 
teleological! This is not to say that these organisms are teleological because they 
survived; this is the teleological interpretation of Darwin’s thought that modern 
scientific thought never tires of attacking. In expounding his theory of natural 
selection, Darwin reaffirmed the teleological force of nature which is at the heart 
of the natural process of evolution.9
 8 Charles Darwin, The Origin of Species: by Means of Natural Selection (Middlesex: Senate, 
1998), 2.
 9 Kass, Toward a More Natural Science, 260-61.
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As Professor Marjorie Greene10 has pointed out to many philosophical 
biologists, especially those trained in the atmosphere of British science: only 
that which is non-living is real, because only what is non-living can be explained 
in terms of molecules. This mode of thinking is not concerned with Being, 
the autonomous, dynamic organization and potentiality of the living creature, 
because it cannot explain it!
A Teleological Approach to the Human Genome
Michael Polanyi remarks that while teleology has become a dirty word for 
us,11 this was not always the case. Before modern science interpreted Darwin’s 
evolutionary theory in a predominantly mechanistic way, there was no opposition 
to teleological thoughts about man and nature. Not only was man seen to have 
a special purpose or function, but even other living things, with their specific 
integrative structure of organs and tissues.
All this changed with modern science’s mechanistic interpretation of Darwin’s 
origin of the species and modern biology’s attempts to explain life processes in 
terms of chemical and physical mechanisms. Polanyi believes that the major 
obstacle to the possibility of entertaining any sort of teleological views is the 
reduction of life processes to physical and chemical laws. Although in a given 
DNA molecule there is a finite number of physical and chemical mechanisms, still, 
argues Polanyi, we cannot explain and identify with accuracy these mechanisms, 
and therefore, the reduction of life processes into physical and chemical laws 
is, to say the least, premature. Completely chemical and physical explanations 
for certain crucial aspects of living things have not been found, in spite of the 
momentous discovery of DNA.12 Although it has generally been assumed that 
since organisms are mechanisms, and since mechanisms work in accordance with 
physical and chemical laws, organisms must also work in the same way, biological 
mechanisms cannot be explained as the resultants of the operation of physical 
and chemical laws only. This is because there are two aspects of a biological 
mechanism that must be taken into account and these are (i) the factual aspect 
comprising the physical and chemical conditions which permit the physical and 
chemical reactions specific to the particular mechanism to take place and (ii) the 
boundary conditions or limits within which the particular physical and chemical 
 10 Marjorie Grene, “The Faith of Darwinism,” in The Knower and the Known, (New York: 
Basic Books, 1966), 185.
 11 Michael Polanyi and Harry Prosch, Meaning (Chicago: University of Chicago Press,1975), 
163.
 12 Ibid., 167.
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reactions take place. These boundary conditions, for Polanyi, determine the 
pattern in which these physical and chemical interactions are put together 
rather than the way in which these physical and chemical parts interact with 
one another. For Polanyi, although all living organisms appear to function in a 
way that appears to be guided by meaningful boundary conditions, a mechanism 
acquires its organization by reference to some aim or goal or purpose that is to be 
achieved by it, and this purpose cannot be deduced from the physico-chemical 
aspect of the mechanism.13
 In other words, the dynamics of a living cell cannot be explained by 
reduction to the laws governing DNA molecules because in the molecules of 
life there is a fantastic configuration of forms and activities which require 
being studied in yet another dimension. While the shaping of the boundaries 
which are represented by the physical-chemical forms establishes a “controlling 
principle,” the system itself is put under the control of a non-physical-chemical 
principle by a “profoundly informative intervention.”14 Polanyi believes that life 
is characterized by a “striving forward” which can be explained as a “gradient” 
towards higher forms and self-consciousness. The high level of genetic possibilities 
in man, as compared with a lower animal, is a manifestation of this striving, and 
each individual, as it comes into being, is a fresh manifestation of the attempt 
by life to develop potentialities. As Polanyi points out, the apparent simplicity 
of the chemical composition of the DNA molecule masks the complexity of the 
process involved in the generation of new life, and the qualitative progression in 
the evolution of the species and the generation of life within the same species. In 
this regard, Charles Taylor, writing on the subject of Galilean principles, argues 
that to transpose these scientific principles from inanimate to animate behavior 
“is to make a speculative leap, not to enunciate a necessary condition.” 15
The Anti-Commons Effect: When the Juridical Clashes 
with the Ethical
These metaphysical reflections on the human genome can never be reconciled 
with the patenting of human genes which makes parts of the human genome 
subject to appropriation by individuals and groups through the granting of 
intellectual property rights. As has been demonstrated, the human genome 
 13 Michael Polanyi, “Life Transcending Physics and Chemistry,” Chemical and Engineering 
News 45 (1967): 54-66.
 14 Ibid.
 15 Charles Taylor, The Explanation of Behaviour (London: Routledge & Kegan Paul, 1980), 
25.
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is not a collection of genes that can be explored and exploited but rather, the 
human genome is a metaphysical reality that defies the method of scientific 
control. For these reasons, the human genome has been at the centre of recent 
bioethical debates because many institutions, scientists and individuals are 
worried that the patenting of human genes is creating an anti-commons effect 
that impedes the progress of scientific research. As a result, there are long delays 
in the development of new medical treatments and therapies that can bring relief 
to thousands of individuals who are suffering from some serious illness. It has 
been estimated that in the United States alone, at least 20% of all human genes 
are already under patent.
Ironically, when the patent system was introduced, it was intended to 
encourage scientific progress and not impede it. It was meant to do this by 
providing inventors, investors and entrepreneurs with incentives to carry on 
doing biomedical research by granting them a right of ownership on their 
invention for a specified period of time. In exchange for this protection, the 
patentee was obliged to disclose information about his/her invention together 
with the patent application.
The problem with the patenting of human genes is that holders of gatekeeper 
patents exercise excessive control over the commercial fruits of genome research. 
Similarly, allowing multiple patents on different parts of the genomic sequence, 
such as a gene fragment, a gene or a protein, adds undue costs to a researcher who 
wants to examine the sequence. The researcher might need to pay royalties on 
hundreds of patents in order to be able to develop a new product.16
These are some of the factors that give rise to the anti-commons effect in the 
biotechnology industry, impeding researchers from making new discoveries and 
developing new products. Recently the Supreme Court in the United States has 
ruled that the patents claimed by Myriad Genetics on the BRCA1 and BRCA2 
gene mutations were preventing vital research on breast, ovarian and other 
cancers. While the Supreme Court upheld the patent eligibility of cDNA since 
it is not naturally occurring, it ruled that that isolated DNA, or genes found in 
nature are not patentable subject matter.
Several patents on BRCA1 and BRCA2 were granted by the US Patent and 
Trademark Office between 1997 and 2000. In Europe, three patents on the 
BRCA1 were granted by the European Patent Office (EPO) in 2001 while two 
BRCA2 patents were granted in 2003 and 2004 respectively. In the meantime, 
several European laboratories were already offering diagnostic tests for BRCA1 
 16 David B. Resnik, “A Biotechnology Patent Pool: An Idea Whose Time Has Come?,” 
The Journal of Philosophy, Science and Law, 3 (2003), http://www6.miami.edu/ethics/jpsl/
archives/papers/biotechPatent.html
46 MELITA THEOLOGICA
and BRCA2 using different methods for mutation detection. With the granting 
of the patents by the EPO, Myriad Genetics adopted a policy of not licensing 
the diagnostic test, or at least not at conditions that were acceptable to the 
laboratories. As a result, several groups of European geneticists appealed against 
the patents with the EPO.
Precisely in order to avoid a similar situation from happening again, several 
commentators have in recent years, been proposing to make the human genome 
a “common heritage of mankind” that puts the interests of mankind above both 
individual and community interests. With the “common heritage of mankind,” 
an intellectual sanctuary would be created where intellectual property would 
not apply. A system of compulsory licensing would also be introduced so as to 
ensure that patentees would not be able to exclude other researchers from having 
access to knowledge related to their patent.
The political decision to declare the human genome a “common heritage of 
mankind” would carry with it five fundamental ethical implications, namely, that 
(i) the human genome must not be made subject to appropriation of any kind 
whether public or private; (ii) the management of the human genome must be 
carried out by and on behalf of all humanity by “trustee” representatives; (iii) any 
benefits derived from such management must be shared among all humanity; 
(iv) the use of the human genome must be limited to peaceful purposes; and 
finally, (v) scientific research on the human genome must be carried out freely 
so long as the human genome is not compromised in any way, and the results are 
openly published for the benefit of all humanity.17
While the application of the patent system in the field of biotechnology 
and biomedicine has seemed justified in the past as a way of ensuring a 
reasonable balance between the rights of inventors and the public interest, many 
commentators are beginning to question the ethical and legal legitimacy of 
granting exclusive proprietary rights on human genes. These concerns revolve 
mainly around the idea that as the human genome stands for both (i) the full set 
of genes of each individual and (ii) the full range of genes of the human species, 
it can never be made the object of exclusionary intellectual property rights for 
any reason whatsoever.
Building a Political Platform for the Human Genome
For these reasons, there have been, in the past years, several attempts to 
encourage the adoption of new legislation that would guarantee a more equitable 
 17 Arvid Pardo, The Common Heritage of Mankind: Selected Papers on Oceans and World Order 
1967-1974 (Msida: Malta University Press 1975), 1-41.
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and sustainable use of biotechnology. These concerted efforts have produced 
a number of notable results, including the Council of Europe Convention 
on Biomedicine18with its related Protocols on Human Cloning19 and the 
Transplantation of Organs and Tissues of Human Origin and Biomedical 
Research;20 the UNESCO Universal Declaration on the Human Genome and 
Human Rights21 and the related Declaration on Human Genetic Data;22 the UN 
Declaration on Human Cloning23 and, the EC Directive on Biotechnological 
Interventions.24
The Council of Europe’s Committee on Legal and Human Rights has also 
called upon member states to change the basis of patent law with respect to 
rights of ownership over human tissue and genes into “law pertaining to the 
common heritage of mankind.”25 The Parliamentary Assembly of the European 
Union has found it expedient to recommend to member states that they should 
strive towards establishing a “suitable alternative system of protecting intellectual 
property in the field of biotechnology” which would replace the present patent 
system that is considered to be inadequate for dealing with the discovery of 
human genes in particular.26 The Parliamentary Assembly recommended that 
this proposed new system should be founded on a principle of “common heritage 
of mankind” which should reflect the language of the Universal Declaration on 
the Human Genome and Human Rights. This Declaration was adopted by the 
 18 Council of Europe, Convention for the Protection of Human Rights and Dignity of the Human 
Being with regard to the Application of Biology and Medicine, Oviedo, 4 April 1997, CETS, no.164 
(Strasbourg: Council of Europe, 1998).
 19 Council of Europe, Additional Protocol to the Convention for the Protection of Human Rights 
and Dignity of the Human Being with regard to the Application of Biology and Medicine, on the 
Prohibition of Cloning Human Beings, Paris, 12 January 1998, CETS, no.168 (Strasbourg: 
Council of Europe, 1998).
 20 Council of Europe, Additional Protocol to the Convention on Human Rights and Biomedicine 
concerning Transplantation of Organs and Tissues of Human Origin, Strasbourg, 24 Jan 2002, 
CETS, no.186 (Strasbourg: Council of Europe, 2002).
 21 UNESCO, Declaration on the Human Genome. 
 22 UNESCO, International Declaration on Human Genetic Data Adopted by the General 
Conference of UNESCO at its 32nd Session on 16 October 2003 (Paris: UNESCO, 2004).
 23 Declaration on Human Cloning Adopted by the General Assembly of the United Nations 
at its 59th Session on 8 March 2005. UNGA Resolution 59/280.
 24 Directive 98/44/EC of the European Parliament and of the Council, of 6 July 1998 on the 
Legal Protection of Biotechnological Inventions, OJL 213, 30 July 1998, 13-21.
 25 Parliamentary Assembly of the Council of Europe Recommendation 1512 (2001) on the 
Protection of the Human Genome.
 26 Parlamentary Assembly of the Council of Europe Recommendation 1425 (1999) on 
Biotechnology and Intellectual Property, par. 13.
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General Conference of UNESCO in 1997 as a result of the urgent need, felt by 
the international community, to provide itself with an international instrument 
more particularly focused on the human genome. Article 1 of the UNESCO 
Declaration states that: “The human genome underlies the fundamental unity 
of all members of the human family, as well as the recognition of their inherent 
dignity and diversity. In a symbolic sense, it is the heritage of humanity.”27
It is precisely because the genes themselves are the place where genomic 
information is stored that the human genome can be called the “heritage of 
mankind.” It follows that, as a common inheritance, the human genome can never 
be appropriated by anyone. In practical terms, a new governance of the human 
genome must strike a balance between rewarding and protecting an inventor for 
his/her research work and ensuring that the inventor’s research is made freely 
and rapidly available to other researchers, in the interests of “mankind.”
The Human Genome as the Embodiment of Our Humanity
The commercialization of the human genome has seemed justified until 
now on the grounds that the human genome is reducible to a collection of 
“genes” and “gene fragments” that, as “natural matter,” can be made the object 
of exclusionary intellectual property rights. This reductionist view of the human 
genome devalues its true nature by obfuscating its ontological significance as the 
embodiment of our humanness, determining both our individual and species 
identity. These two different approaches represent the divide that exists between 
those who believe that there is no metaphysical reality that underlies the human 
genome, and those who believe that it is only by giving serious consideration to 
its metaphysical nature that we will be able to comprehend the human genome’s 
true essential nature.
This divergence of opinions on the nature of the human genome is also 
reflected in the issues raised by a number of contemporary scientists and 
philosophers, on the kind of biotechnology that is being used by biotech 
companies to exploit the human genome. Jurgen Habermas argues that there 
are many applications of biotechnology that are violating our dignity as human 
persons, such as the use of biotechnology to selectively modify and/or engineer 
specific genetic traits for purely enhancement purposes.28 Accordingly, he 
argues in favour of an unmanipulated genetic heritage because any such genetic 
manipulation would touch the core of our identity as human beings.29 Habermas’ 
 27 UNESCO, Declaration on the Human Genome.
 28 Jurgen Habermas, The Future of Human Nature (Cambridge: Polity Press, 2003), 16-74.
 29 Ibid.
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criticism of biotechnology, like that of other philosophers who are critical of 
certain applications of modern biotechnology, is based on his concern that 
several applications of biotechnology during the last twenty years have ignored 
the metaphysical understanding of human nature that must be at the heart of all 
bioethical debates involving the human genome.
The concept of common heritage of mankind can constitute the nexus 
between biotechnology and the human genome. In this sense it is the concept of 
“common heritage of mankind” that can restore meaning and significance to the 
human genome as the embodiment of our humanity.
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